Centene Corp (CNC) reports a mixed quarter with revenue growth but faces earnings pressure, while outlining strategic plans for margin recovery and future profitability.

Centene ( ($CNC) ) has released its Q2 earnings. Here is a breakdown of the information Centene presented to its investors. Centene Corporation is ...

Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.

Discover Centene Corporation's Q2 2025 earnings analysis, uncovering setbacks, repricing strategies, and plans for profitability restoration.

Detailed price information for Lockheed Martin Corp (LMT-N) from The Globe and Mail including charting and trades.

Volkswagen Teases Made-in-America Audis After $1.5 Billion Tariff Hit The German automaker said it expects challenges due to political uncertainty, expanding trade restrictions and geopolitical ...

State Medicaid systems are scrambling to prepare for painful cuts under the One Big Beautiful Bill Act, leaving private ...

Health insurance Centene Corp. announced losses during its most recent quarter, citing rising Medicaid costs and a change in membership. In the same period last year, Centene saw earnings of $2.26 a ...

Centene Corporation's Q2 2025 results revealed a loss per share and revenue figures that diverged from expectations.